| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |